Specimen Rejection Rate serves as a critical performance indicator for laboratories, impacting operational efficiency and financial health.
High rejection rates can lead to increased costs and delays, affecting patient care and overall business outcomes.
Conversely, low rates indicate effective quality control and streamlined processes, enhancing service delivery.
Organizations that monitor this KPI can improve forecasting accuracy and align operations with strategic goals.
By leveraging analytical insights, labs can identify root causes of rejections, leading to better cost control metrics.
Ultimately, a focus on this KPI fosters data-driven decision-making and enhances the laboratory's reputation in the healthcare ecosystem.
High specimen rejection rates signal underlying issues in sample collection, handling, or processing, which can compromise patient outcomes. Low rates reflect robust quality assurance practices and efficient workflows. Ideal targets typically fall below a 5% rejection rate.
We have 16 relevant benchmarks in our benchmarks database.
Source: Subscribers only
Source Excerpt: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | Africa | subgroup within 26 articles |
Source: Subscribers only
Source Excerpt: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | Europe | subgroup within 26 articles |
Source: Subscribers only
Source Excerpt: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | America | subgroup within 26 articles |
Source: Subscribers only
Source Excerpt: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | Asia | subgroup within 26 articles |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | global | 26 articles; 16,118,499 blood sample requests |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | hematology tubes | hematology | China | 661 laboratories |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | complete blood count specimens | clinical laboratory | 703 laboratories |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | percentiles | clinical chemistry specimens | clinical laboratory | North America | 453 institutions |
Source: Subscribers only
Source Excerpt: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | Africa | subgroup within 26 articles |
Source: Subscribers only
Source Excerpt: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | Europe | subgroup within 26 articles |
Source: Subscribers only
Source Excerpt: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | America | subgroup within 26 articles |
Source: Subscribers only
Source Excerpt: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | Asia | subgroup within 26 articles |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | pooled prevalence | 2009-2020 (included studies) | blood sample requests | clinical laboratory | global | 26 articles; 16,118,499 blood sample requests |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | hematology tubes | hematology | China | 661 laboratories |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | complete blood count specimens | clinical laboratory | 703 laboratories |
Source: Subscribers only
Source Excerpt: Subscribers only
Additional Comments: Subscribers only
| Value | Unit | Type | Company Size | Time Period | Population | Industry | Geography | Sample Size |
| Subscribers only | percent | percentiles | clinical chemistry specimens | clinical laboratory | North America | 453 institutions |
Many laboratories overlook the importance of tracking specimen rejection rates, leading to inefficiencies that can erode trust and increase operational costs.
Enhancing specimen acceptance rates requires a focus on process optimization and staff engagement.
A leading diagnostic laboratory faced a troubling increase in its specimen rejection rate, which had climbed to 8%. This spike not only delayed test results but also strained relationships with healthcare providers. In response, the lab initiated a comprehensive quality improvement program focused on enhancing specimen collection and processing protocols.
The initiative involved retraining staff on best practices and implementing a new digital tracking system for specimens. This system allowed for real-time monitoring of samples, enabling quick identification of potential issues. Additionally, the lab established a feedback mechanism where technicians could report challenges in the collection process, fostering a culture of continuous improvement.
Within 6 months, the lab successfully reduced its rejection rate to 3%, significantly improving turnaround times and client satisfaction. The financial impact was notable, as reduced rejections translated to lower operational costs and increased revenue from repeat business. The lab's commitment to quality not only enhanced its reputation but also positioned it as a leader in diagnostic services.
This KPI is associated with the following categories and industries in our KPI database:
KPI Depot takes you from KPI intelligence to finished deliverable. Consultants, strategy teams, FP&A leaders, and analytics teams use it to answer the two hardest questions in performance management, what to measure and what the target should be, and then to produce the scorecard itself.
The difference is intelligence, not just data. Anyone can list metrics. Every KPI in KPI Depot carries 13 practical attributes, from formula and measurement approach to diagnostic questions, risk warnings, and Balanced Scorecard perspective, across 15 corporate functions and 153 industries. And every target you set is grounded in our database of 34,304 source-attributed benchmarks, each detailing metric value, company size, time period, industry, geography, sample size, and source. Benchmark data at this scale is otherwise the domain of research services costing thousands to hundreds of thousands of dollars per year.
When your metrics are selected, KPI Depot finishes the job: export an interactive Strategy Map, a Balanced Scorecard with formulas and tracking columns, or a CSV KPI pack, and go from research to working deliverable in hours instead of weeks.
Formerly the Flevy KPI Library, KPI Depot is trusted by teams at organizations including Accenture, EY, IBM, PepsiCo, Samsung, and Vodafone.
Got a question? Email us at [email protected].
Common factors include improper collection techniques, inadequate labeling, and delays in processing. Each of these issues can compromise sample integrity and lead to increased rejections.
Implementing a robust reporting dashboard can streamline tracking efforts. Regularly reviewing this data allows laboratories to identify trends and address issues proactively.
High rejection rates can lead to increased operational costs and delayed results. They can also damage relationships with healthcare providers, impacting overall business performance.
Monthly reviews are advisable for most laboratories. Frequent monitoring helps identify issues early and allows for timely interventions.
Yes, technology can enhance tracking and processing accuracy. Automated systems reduce human error and improve overall operational efficiency.
Comprehensive training ensures that staff are aware of best practices. Well-trained employees are less likely to make errors that lead to specimen rejections.
Each KPI in our knowledge base includes 13 attributes.
A clear explanation of what the KPI measures
The typical business insights we expect to gain through the tracking of this KPI
An outline of the approach or process followed to measure this KPI
The standard formula organizations use to calculate this KPI
Insights into how the KPI tends to evolve over time and what trends could indicate positive or negative performance shifts
Questions to ask to better understand your current position is for the KPI and how it can improve
Practical, actionable tips for improving the KPI, which might involve operational changes, strategic shifts, or tactical actions
Recommended charts or graphs that best represent the trends and patterns around the KPI for more effective reporting and decision-making
Potential risks or warnings signs that could indicate underlying issues that require immediate attention
Suggested tools, technologies, and software that can help in tracking and analyzing the KPI more effectively
How the KPI can be integrated with other business systems and processes for holistic strategic performance management
Explanation of how changes in the KPI can impact other KPIs and what kind of changes can be expected
NEW Mapping to a Balanced Scorecard perspective (financial, customer, internal process, learning & growth)